1
BRIDGEBIO PHARMA INC
COM
BBIO
BBIO
910,070
$23.1m3.76%
3.76%
Added Shares held: Q3 2023 345.5k, Q4 2023 282.1k, Q1 2024 586.0k, Q2 2024 910.1k
+324.1k
+324,114
55.3%
2
SANOFI
SPONSORED ADR
SNY
SNY
449,515
$21.8m3.55%
3.55%
Reduced Shares held: Q3 2023 499.5k, Q4 2023 499.5k, Q1 2024 499.5k, Q2 2024 449.5k
-50.0k
-50,000
-10.0%
3
CYTOKINETICS INC
COM NEW
CYTK
CYTK
384,924
$20.9m3.40%
3.40%
Added Shares held: Q3 2023 233.9k, Q4 2023 223.8k, Q1 2024 281.7k, Q2 2024 384.9k
+103.3k
+103,253
36.7%
4
AMAZON COM INC
COM
AMZN
AMZN
101,432
$19.6m3.19%
3.19%
Added Shares held: Q3 2023 95.3k, Q4 2023 55.7k, Q1 2024 54.4k, Q2 2024 101.4k
+47.0k
+47,000
86.3%
5
SYNDAX PHARMACEUTICALS INC
COM
SNDX
SNDX
822,047
$16.9m2.75%
2.75%
Added Shares held: Q3 2023 773.1k, Q4 2023 773.0k, Q1 2024 813.0k, Q2 2024 822.0k
+9.1k
+9,083
1.1%
6
META PLATFORMS INC
CL A
META
META
33,439
$16.9m2.75%
2.75%
Added Shares held: Q3 2023 15.2k, Q4 2023 34.3k, Q1 2024 25.4k, Q2 2024 33.4k
+8.0k
+8,000
31.4%
7
ASTRAZENECA PLC
SPONSORED ADR
SPONSORED ADR
190,060
$14.8m2.42%
2.42%
Unchanged Shares held: Q3 2023 285.1k, Q4 2023 180.1k, Q1 2024 190.1k, Q2 2024 190.1k
8
MICROSOFT CORP
COM
MSFT
MSFT
32,927
$14.7m2.40%
2.40%
Added Shares held: Q3 2023 34.4k, Q4 2023 23.8k, Q1 2024 27.5k, Q2 2024 32.9k
+5.4k
+5,379
19.5%
9
NICE LTD
SPONSORED ADR
NICE
NICE
81,461
$14.0m2.28%
2.28%
Reduced Shares held: Q3 2023 37.5k, Q4 2023 67.7k, Q1 2024 85.9k, Q2 2024 81.5k
-4.4k
-4,420
-5.2%
10
SAREPTA THERAPEUTICS INC
COM
SRPT
SRPT
83,659
$13.2m2.15%
2.15%
Added Shares held: Q3 2023 50.0k, Q4 2023 12.5k, Q1 2024 55.6k, Q2 2024 83.7k
+28.0k
+28,045
50.4%
11
APPLE INC
COM
AAPL
AAPL
61,500
$13.0m2.11%
2.11%
Added Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 17.5k, Q2 2024 61.5k
+44.0k
+44,000
251.4%
12
TEVA PHARMACEUTICAL INDS LTD
SPONSORED ADS
SPONSORED ADS
789,416
$12.8m2.09%
2.09%
Reduced Shares held: Q3 2023 600.0k, Q4 2023 2.5m, Q1 2024 1.9m, Q2 2024 789.4k
-1.1m
-1,100,284
-58.2%
13
KURA ONCOLOGY INC
COM
KURA
KURA
610,826
$12.6m2.05%
2.05%
Unchanged Shares held: Q3 2023 703.3k, Q4 2023 703.3k, Q1 2024 610.8k, Q2 2024 610.8k
14
ULTRAGENYX PHARMACEUTICAL IN
COM
RARE
RARE
293,832
$12.1m1.97%
1.97%
Added Shares held: Q3 2023 259.1k, Q4 2023 201.0k, Q1 2024 238.5k, Q2 2024 293.8k
+55.3k
+55,288
23.2%
15
ELI LILLY & CO
COM
LLY
LLY
13,190
$11.9m1.95%
1.95%
Reduced Shares held: Q3 2023 14.2k, Q4 2023 14.2k, Q1 2024 14.2k, Q2 2024 13.2k
-1.0k
-1,000
-7.0%
16
PRAXIS PRECISION MEDICINES I
COM NEW
PRAX
PRAX
283,424
$11.7m1.91%
1.91%
Added Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 177.1k, Q2 2024 283.4k
+106.3k
+106,285
60.0%
17
CELLDEX THERAPEUTICS INC NEW
COM NEW
CLDX
CLDX
309,265
$11.4m1.87%
1.87%
Added Shares held: Q3 2023 180.0k, Q4 2023 315.6k, Q1 2024 277.0k, Q2 2024 309.3k
+32.3k
+32,269
11.7%
18
NOVO-NORDISK A S
ADR
NVO
NVO
78,080
$11.1m1.82%
1.82%
Reduced Shares held: Q3 2023 93.1k, Q4 2023 93.1k, Q1 2024 83.1k, Q2 2024 78.1k
-5.0k
-5,000
-6.0%
19
BIOGEN INC
COM
BIIB
BIIB
47,412
$11.0m1.79%
1.79%
Reduced Shares held: Q3 2023 25.8k, Q4 2023 46.3k, Q1 2024 70.6k, Q2 2024 47.4k
-23.2k
-23,234
-32.9%
20
SKYE BIOSCIENCE INC
COM NEW
COM NEW
1,298,312
$10.4m1.69%
1.69%
New Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 1.3m
21
JASPER THERAPEUTICS INC
COM NEW
JSPR
JSPR
454,227
$10.3m1.68%
1.68%
Reduced Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 505.2k, Q2 2024 454.2k
-51.0k
-51,015
-10.1%
22
JOHNSON & JOHNSON
COM
JNJ
JNJ
69,831
$10.2m1.66%
1.66%
Reduced Shares held: Q3 2023 94.8k, Q4 2023 79.8k, Q1 2024 79.8k, Q2 2024 69.8k
-10.0k
-10,000
-12.5%
23
ASML HOLDING N V
N Y REGISTRY SHS
ASML
ASML
9,901
$10.1m1.65%
1.65%
New Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 9.9k
24
MERUS N V
COM
MRUS
MRUS
147,633
$8.7m1.42%
1.42%
Reduced Shares held: Q3 2023 253.3k, Q4 2023 230.3k, Q1 2024 149.3k, Q2 2024 147.6k
-1.7k
-1,700
-1.1%
25
SALESFORCE INC
COM
CRM
CRM
33,600
$8.6m1.41%
1.41%
New Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 33.6k
26
IMMATICS N.V
SHS
IMTX
IMTX
731,111
$8.5m1.38%
1.38%
Added Shares held: Q3 2023 617.2k, Q4 2023 621.1k, Q1 2024 666.1k, Q2 2024 731.1k
+65.0k
+65,000
9.8%
27
PERSPECTIVE THERAPEUTICS INC
COM NEW
CATX
CATX
786,909
$7.8m1.28%
1.28%
New Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 786.9k
28
PHARVARIS N V
COM
PHVS
PHVS
403,265
$7.6m1.24%
1.24%
Added Shares held: Q3 2023 0, Q4 2023 245.0k, Q1 2024 392.9k, Q2 2024 403.3k
+10.4k
+10,388
2.6%
29
MERCK & CO INC
COM
MRK
MRK
59,600
$7.4m1.20%
1.20%
Reduced Shares held: Q3 2023 123.6k, Q4 2023 123.6k, Q1 2024 103.6k, Q2 2024 59.6k
-44.0k
-44,000
-42.5%
30
REZOLUTE INC
COM NEW
RZLT
RZLT
1,707,999
$7.3m1.20%
1.20%
Added Shares held: Q3 2023 996.7k, Q4 2023 996.7k, Q1 2024 996.7k, Q2 2024 1.7m
+711.3k
+711,289
71.4%
31
CYBIN INC
COM
COM
25,581,395
$6.9m1.13%
1.13%
Unchanged Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 25.6m, Q2 2024 25.6m
32
VIGIL NEUROSCIENCE INC
COM
VIGL
VIGL
1,692,166
$6.8m1.10%
1.10%
Reduced Shares held: Q3 2023 0, Q4 2023 535.1k, Q1 2024 1.7m, Q2 2024 1.7m
-38.2k
-38,248
-2.2%
33
IONIS PHARMACEUTICALS INC
COM
IONS
IONS
140,238
$6.7m1.09%
1.09%
New Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 140.2k
34
INOZYME PHARMA INC
COM
COM
1,462,724
$6.5m1.06%
1.06%
Added Shares held: Q3 2023 1.2m, Q4 2023 1.6m, Q1 2024 1.4m, Q2 2024 1.5m
+89.8k
+89,817
6.5%
35
ABBVIE INC
COM
ABBV
ABBV
38,000
$6.5m1.06%
1.06%
Unchanged Shares held: Q3 2023 46.0k, Q4 2023 46.0k, Q1 2024 38.0k, Q2 2024 38.0k
36
PALO ALTO NETWORKS INC
COM
PANW
PANW
18,000
$6.1m0.99%
0.99%
New Shares held: Q3 2023 28.8k, Q4 2023 16.6k, Q1 2024 0, Q2 2024 18.0k
37
SENTINELONE INC
CL A
S
S
283,804
$6.0m0.97%
0.97%
Reduced Shares held: Q3 2023 0, Q4 2023 213.4k, Q1 2024 550.8k, Q2 2024 283.8k
-267.0k
-267,014
-48.5%
38
TOWER SEMICONDUCTOR LTD
SHS NEW
TSEM
TSEM
149,600
$5.9m0.96%
0.96%
Reduced Shares held: Q3 2023 469.6k, Q4 2023 528.3k, Q1 2024 179.6k, Q2 2024 149.6k
-30.0k
-30,000
-16.7%
39
APPLIED MATLS INC
COM
AMAT
AMAT
24,604
$5.8m0.95%
0.95%
Reduced Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 32.0k, Q2 2024 24.6k
-7.4k
-7,396
-23.1%
40
ENPHASE ENERGY INC
COM
ENPH
ENPH
56,792
$5.7m0.92%
0.92%
Added Shares held: Q3 2023 0, Q4 2023 34.8k, Q1 2024 47.2k, Q2 2024 56.8k
+9.6k
+9,609
20.4%
41
NOVARTIS AG
SPONSORED ADR
NVS
NVS
50,000
$5.3m0.87%
0.87%
Unchanged Shares held: Q3 2023 60.0k, Q4 2023 60.0k, Q1 2024 50.0k, Q2 2024 50.0k
42
ACADIA PHARMACEUTICALS INC
COM
ACAD
ACAD
327,539
$5.3m0.87%
0.87%
Added Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 125.0k, Q2 2024 327.5k
+202.5k
+202,539
162.0%
43
MINERALYS THERAPEUTICS INC
COM
MLYS
MLYS
442,752
$5.2m0.84%
0.84%
Reduced Shares held: Q3 2023 455.4k, Q4 2023 743.6k, Q1 2024 658.8k, Q2 2024 442.8k
-216.1k
-216,051
-32.8%
44
4D MOLECULAR THERAPEUTICS IN
COM
FDMT
FDMT
242,526
$5.1m0.83%
0.83%
Added Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 162.2k, Q2 2024 242.5k
+80.4k
+80,365
49.6%
45
MICRON TECHNOLOGY INC
COM
MU
MU
37,000
$4.9m0.79%
0.79%
New Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 37.0k
46
DAY ONE BIOPHARMACEUTICALS I
COM
COM
347,627
$4.8m0.78%
0.78%
Reduced Shares held: Q3 2023 530.0k, Q4 2023 513.0k, Q1 2024 492.6k, Q2 2024 347.6k
-145.0k
-145,000
-29.4%
47
CATALYST PHARMACEUTICALS INC
COM
CPRX
CPRX
288,000
$4.5m0.73%
0.73%
Unchanged Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 288.0k, Q2 2024 288.0k
48
ROCKET PHARMACEUTICALS INC
COM
RCKT
RCKT
206,933
$4.5m0.73%
0.73%
Added Shares held: Q3 2023 209.0k, Q4 2023 190.8k, Q1 2024 183.7k, Q2 2024 206.9k
+23.2k
+23,211
12.6%
49
JFROG LTD
ORD SHS
FROG
FROG
117,881
$4.4m0.72%
0.72%
Reduced Shares held: Q3 2023 0, Q4 2023 109.9k, Q1 2024 224.4k, Q2 2024 117.9k
-106.5k
-106,500
-47.5%
50
89BIO INC
COM
ETNB
ETNB
526,547
$4.2m0.69%
0.69%
Added Shares held: Q3 2023 319.3k, Q4 2023 408.7k, Q1 2024 515.9k, Q2 2024 526.5k
+10.7k
+10,665
2.1%
51
OUTLOOK THERAPEUTICS INC
COM
OTLK
OTLK
571,428
$4.2m0.69%
0.69%
Reduced Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 571.4k, Q2 2024 571.4k
-1
-1
0.0%
52
WIX COM LTD
SHS
WIX
WIX
25,177
$4.0m0.65%
0.65%
Reduced Shares held: Q3 2023 0, Q4 2023 57.5k, Q1 2024 52.9k, Q2 2024 25.2k
-27.7k
-27,700
-52.4%
53
LAM RESEARCH CORP
COM
COM
3,700
$3.9m0.64%
0.64%
New Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 3.7k
54
SAVARA INC
COM
SVRA
SVRA
962,687
$3.9m0.63%
0.63%
New Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 962.7k
55
GSK PLC
SPONSORED ADR
GSK
GSK
100,000
$3.9m0.63%
0.63%
Unchanged Shares held: Q3 2023 100.0k, Q4 2023 100.0k, Q1 2024 100.0k, Q2 2024 100.0k
56
QUALCOMM INC
COM
QCOM
QCOM
18,825
$3.7m0.61%
0.61%
Added Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 15.0k, Q2 2024 18.8k
+3.8k
+3,825
25.5%
57
ELEDON PHARMACEUTICALS INC
COM
ELDN
ELDN
1,297,021
$3.4m0.56%
0.56%
New Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 1.3m
58
AKERO THERAPEUTICS INC
COM
AKRO
AKRO
141,620
$3.3m0.54%
0.54%
Reduced Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 160.4k, Q2 2024 141.6k
-18.8k
-18,825
-11.7%
59
SHL TELEMEDICINE LTD
SPONSORED ADS
SHLT
SHLT
632,456
$3.2m0.53%
0.53%
Unchanged Shares held: Q3 2023 632.3k, Q4 2023 632.5k, Q1 2024 632.5k, Q2 2024 632.5k
60
APPLIED THERAPEUTICS INC
COM
APLT
APLT
674,268
$3.1m0.51%
0.51%
Added Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 619.0k, Q2 2024 674.3k
+55.2k
+55,239
8.9%
61
INTELLIA THERAPEUTICS INC
COM
NTLA
NTLA
139,419
$3.1m0.51%
0.51%
New Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 139.4k
62
BROADCOM INC
COM
AVGO
AVGO
19,360
$3.1m0.51%
0.51%
Added Shares held: Q3 2023 0, Q4 2023 1.8k, Q1 2024 1.0k, Q2 2024 19.4k
+18.4k
+18,359
1834.1%
63
ANALOG DEVICES INC
COM
ADI
ADI
13,000
$3.0m0.48%
0.48%
New Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 13.0k
64
PTC THERAPEUTICS INC
COM
PTCT
PTCT
94,318
$2.9m0.47%
0.47%
New Shares held: Q3 2023 218.5k, Q4 2023 136.5k, Q1 2024 0, Q2 2024 94.3k
65
VISTAGEN THERAPEUTICS INC
COM
VTGN
VTGN
808,550
$2.8m0.46%
0.46%
Unchanged Shares held: Q3 2023 100.0k, Q4 2023 808.5k, Q1 2024 808.5k, Q2 2024 808.5k
66
PLIANT THERAPEUTICS INC
COM
PLRX
PLRX
258,554
$2.8m0.45%
0.45%
Unchanged Shares held: Q3 2023 156.1k, Q4 2023 193.6k, Q1 2024 258.6k, Q2 2024 258.6k
67
ALECTOR INC
COM
ALEC
ALEC
610,000
$2.8m0.45%
0.45%
Added Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 560.0k, Q2 2024 610.0k
+50.0k
+50,000
8.9%
68
ENLIGHT RENEWABLE ENERGY LTD
SHS
ENLT
ENLT
169,280
$2.7m0.45%
0.45%
Unchanged Shares held: Q3 2023 0, Q4 2023 169.3k, Q1 2024 169.3k, Q2 2024 169.3k
69
PROMIS NEUROSCIENCES INC
COM NEW
PMN
PMN
1,814,213
$2.7m0.44%
0.44%
Reduced Shares held: Q3 2023 1.8m, Q4 2023 1.8m, Q1 2024 1.8m, Q2 2024 1.8m
-19.8k
-19,834
-1.1%
70
KLA CORP
COM NEW
KLAC
KLAC
3,300
$2.7m0.44%
0.44%
New Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 3.3k
71
SPRINGWORKS THERAPEUTICS INC
COM
SWTX
SWTX
70,269
$2.6m0.43%
0.43%
Unchanged Shares held: Q3 2023 319.9k, Q4 2023 170.3k, Q1 2024 70.3k, Q2 2024 70.3k
72
DISC MEDICINE INC
COM
IRON
IRON
58,044
$2.6m0.43%
0.43%
Added Shares held: Q3 2023 111.4k, Q4 2023 0, Q1 2024 48.9k, Q2 2024 58.0k
+9.2k
+9,158
18.7%
73
CARGO THERAPEUTICS INC
COM
COM
155,506
$2.6m0.42%
0.42%
Added Shares held: Q3 2023 0, Q4 2023 75.0k, Q1 2024 75.0k, Q2 2024 155.5k
+80.5k
+80,506
107.3%
74
PFIZER INC
COM
PFE
PFE
90,000
$2.5m0.41%
0.41%
Unchanged Shares held: Q3 2023 90.0k, Q4 2023 90.0k, Q1 2024 90.0k, Q2 2024 90.0k
75
NVIDIA CORPORATION
COM
NVDA
NVDA
20,000
$2.5m0.40%
0.40%
New Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 20.0k
76
GLOBAL E ONLINE LTD
SHS
GLBE
GLBE
66,884
$2.4m0.40%
0.40%
Reduced Shares held: Q3 2023 0, Q4 2023 269.8k, Q1 2024 208.8k, Q2 2024 66.9k
-141.9k
-141,900
-68.0%
77
VENTYX BIOSCIENCES INC
COM
VTYX
VTYX
1,012,749
$2.3m0.38%
0.38%
Added Shares held: Q3 2023 0, Q4 2023 180.0k, Q1 2024 992.7k, Q2 2024 1.0m
+20.0k
+20,000
2.0%
78
TABOOLA.COM LTD
ORD SHS
TBLA
TBLA
667,384
$2.3m0.37%
0.37%
Reduced Shares held: Q3 2023 0, Q4 2023 1.7m, Q1 2024 1.2m, Q2 2024 667.4k
-523.7k
-523,686
-44.0%
79
LARIMAR THERAPEUTICS INC
COM
LRMR
LRMR
312,469
$2.3m0.37%
0.37%
New Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 312.5k
80
L3HARRIS TECHNOLOGIES INC
COM
LHX
LHX
10,000
$2.2m0.37%
0.37%
New Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 10.0k
81
ADC THERAPEUTICS SA
SHS
ADCT
ADCT
685,547
$2.2m0.35%
0.35%
New Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 685.5k
82
NUTRIEN LTD
COM
NTR
NTR
40,730
$2.1m0.34%
0.34%
Added Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 35.7k, Q2 2024 40.7k
+5.0k
+5,000
14.0%
83
PERION NETWORK LTD
SHS NEW
PERI
PERI
234,609
$2.0m0.32%
0.32%
New Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 234.6k
84
KYVERNA THERAPEUTICS INC
COM
KYTX
KYTX
236,029
$1.8m0.29%
0.29%
New Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 236.0k
85
ALUMIS INC
COM
ALMS
ALMS
125,000
$1.7m0.27%
0.27%
New Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 125.0k
86
CLIMB BIO INC
COM
CLYM
CLYM
215,179
$1.5m0.25%
0.25%
New Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 215.2k
87
WEREWOLF THERAPEUTICS INC
COM
HOWL
HOWL
626,810
$1.5m0.25%
0.25%
Unchanged Shares held: Q3 2023 626.8k, Q4 2023 626.8k, Q1 2024 626.8k, Q2 2024 626.8k
88
ASTRIA THERAPEUTICS INC
COM
CATB
CATB
162,842
$1.5m0.24%
0.24%
Added Shares held: Q3 2023 580.6k, Q4 2023 1.2m, Q1 2024 112.8k, Q2 2024 162.8k
+50.0k
+50,000
44.3%
89
VIR BIOTECHNOLOGY INC
COM
VIR
VIR
162,051
$1.4m0.24%
0.24%
New Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 162.1k
90
MONTE ROSA THERAPEUTICS INC
COM
GLUE
GLUE
375,000
$1.4m0.23%
0.23%
New Shares held: Q3 2023 0, Q4 2023 48.5k, Q1 2024 0, Q2 2024 375.0k
91
MARVELL TECHNOLOGY INC
COM
MRVL
MRVL
20,000
$1.4m0.23%
0.23%
New Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 20.0k
92
UPWORK INC
COM
UPWK
UPWK
117,000
$1.3m0.20%
0.20%
Unchanged Shares held: Q3 2023 0, Q4 2023 252.8k, Q1 2024 117.0k, Q2 2024 117.0k
93
ARROWHEAD PHARMACEUTICALS IN
COM
ARWR
ARWR
48,175
$1.3m0.20%
0.20%
New Shares held: Q3 2023 0, Q4 2023 144.9k, Q1 2024 0, Q2 2024 48.2k
94
COMPUGEN LTD
ORD
CGEN
CGEN
739,239
$1.2m0.20%
0.20%
Reduced Shares held: Q3 2023 1.3m, Q4 2023 769.2k, Q1 2024 769.2k, Q2 2024 739.2k
-30.0k
-30,000
-3.9%
95
KEZAR LIFE SCIENCES INC
COM
COM
2,051,676
$1.2m0.20%
0.20%
Unchanged Shares held: Q3 2023 2.1m, Q4 2023 2.1m, Q1 2024 2.1m, Q2 2024 2.1m
96
INSMED INC
COM PAR $.01
INSM
INSM
16,589
$1.1m0.18%
0.18%
New Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 16.6k
97
APREA THERAPEUTICS INC
COM NEW
APRE
APRE
270,000
$1.1m0.18%
0.18%
Unchanged Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 270.0k, Q2 2024 270.0k
98
TAIWAN SEMICONDUCTOR MFG LTD
SPONSORED ADS
TSM
TSM
5,650
$982.0k0.16%
0.16%
New Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 5.7k
99
ELEVATION ONCOLOGY INC
COM
COM
330,000
$891.0k0.15%
0.15%
Reduced Shares held: Q3 2023 900.0k, Q4 2023 900.0k, Q1 2024 430.0k, Q2 2024 330.0k
-100.0k
-100,000
-23.3%
100
VARONIS SYS INC
COM
VRNS
VRNS
16,000
$767.5k0.13%
0.13%
Reduced Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 20.0k, Q2 2024 16.0k
-4.0k
-4,000
-20.0%